We served as counsel to a private equity investment firm related to the financing of a complex buyout and restructuring of a company providing physician management and radiation oncology management services and cancer centers.
Private Equity Buyout and Restructuring of Physician Management and Oncology Services Company
You Also May Be Interested In:
Representation of Life Sciences Company Fagron Holding USA LLC
Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.